Karl Gotthelf Lehmann
Karl Gotthelf Lehmann (1812–1863) was a notable German physician and physiologist. He made significant contributions to the field of physiology and was known for his research in biochemistry and pathology.
Early Life and Education[edit | edit source]
Karl Gotthelf Lehmann was born in Leipzig, Kingdom of Saxony, in 1812. He pursued his medical studies at the University of Leipzig, where he was influenced by prominent scientists of his time. Lehmann earned his medical degree in 1836.
Career[edit | edit source]
After completing his education, Lehmann began his career as a physician and researcher. He held various academic positions, including a professorship at the University of Leipzig. Lehmann's work primarily focused on the chemical processes within the human body, contributing to the early development of biochemistry.
Contributions to Science[edit | edit source]
Lehmann's research in physiology and biochemistry was pioneering. He conducted extensive studies on the composition of bodily fluids and the chemical changes that occur during disease. His work laid the groundwork for future research in clinical chemistry and pathophysiology.
Notable Works[edit | edit source]
Lehmann authored several influential texts, including:
- Lehrbuch der physiologischen Chemie (Textbook of Physiological Chemistry)
- Handbuch der physiologischen Chemie (Handbook of Physiological Chemistry)
These works were widely used in medical education and helped establish the importance of chemical analysis in understanding physiological processes.
Legacy[edit | edit source]
Karl Gotthelf Lehmann's contributions to medicine and physiology have had a lasting impact. His research helped bridge the gap between chemistry and medicine, paving the way for modern biochemistry and clinical pathology.
Related Pages[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD